{
  "main_header": {
    "sid": 905552,
    "name": "Anuh Pharma",
    "stock_name": "Anuh Pharma",
    "full_name": "Anuh Pharma Ltd",
    "name_url": "stocks-analysis/anuh-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "73.90",
    "chg": 0.79,
    "chgp": "1.08%",
    "dir": 1,
    "prev_price": "73.11",
    "mcapval": "717.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506260,
    "symbol": "ANUHPHR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE489G01022",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "25.81 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/anuh-pharma-905552-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 5103,
    "sid": "905552",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/anuh-pharma-905552"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Wednesday 01st April 2026 till the expiry of 48 hours after the declaration of Audited Financial Results for the Quarter and Year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) - Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And Our Facilities Were Found Compliant Under The Audit.",
      "datetime": "06-Mar-2026",
      "details": "Completion of European Directorate for the Quality of Medicines & Healthcare (EDQM) Audit and our facilities were found compliant under the Audit",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Feb-2026",
      "details": "Newspaper Publication regarding notice to shareholders for Special Window for transfer and dematerialisation (demat) of physical shares in reference to SEBI Circular dated January 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has announced <strong>5:10</strong> stock split, ex-date: 31 Jul 06",
          "dt": "2006-07-31",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News